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ABSTRACT 
 
Aims: To evaluate nitrate reductase assay for detection of multi-drug resistant Mycobacterium 
tuberculosis among patients at National Tuberculosis Reference Laboratory Zaria Nigeria. 
Study Design: Hospital based cross sectional study 
Place and Duration of Study: National Tuberculosis Reference Laboratory Zaria Nigeria from 
December 2015 to June 2016. 
Methodology: A total of 437 re-treatment patients’ samples were screened for Acid Fast Bacilli 
(AFB), 72 were smear positive. Out of 72 smears positive, 62 were culture positive, using 
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Lowenstein Jensen medium, 57 were found to be Mycobacterium tuberculosis complex (MTBC) 
using immunochromatographic test. In this study the susceptibility of 57 MTBC isolates to isoniazid 
(INH), rifampicin (RIF), streptomycin (STR) and Ethambutol (EMB) was determined by Lowenstein 
Jensen proportion method (LJPM) and Nitrate Reductase Assay (NRA) 
Results: The sensitivity and specificity of NRA compared to that of LJPM were observed to be 98% 
and 89%, 98% and 92%, 64% and 80%, 68% and 77% for RIF, INH, STR, and EMB respectively. 
Positive predictive values were 91%, 93%, 87% and 83% for RIF, INH, STR and EMB respectively. 
Negative predictive values were 80%, 92%, 67% and 90% for RIF, INH, STR and EMB respectively 
.Overall, the sensitivity, specificity ,positive predictive value and negative predictive value of NRA in 
detecting MDR-TB were 90%,82%,85%and 73% respectively. Good agreement was found in all the 
tests with κ values of 0.63, 0.61, 0.61 and 0.62 for RIF, INH, EMB and MDR-TB respectively only 
STR shows moderate agreements with k value of 0.59.  
Conclusion: In the emergence of MDR-TB, the NRA may be of great importance due to its higher 
sensitivity and specificity for the rapid detection of rifampicin and isoniazid resistance, the two most 
important drugs for tuberculosis treatment. On the basis of our findings, NRA has the potential to be 
a useful tool for accurate detection of MDR-TB in the study area. 
 
 
Keywords: Multidrug resistant TB; nitrate reductase assay; LJ proportion method; drug susceptibility 
testing. 
 
1. INTRODUCTION  
 
Tuberculosis (TB) is causing more deaths 
worldwide than any other infectious disease. The 
World Health Organization (WHO) estimated that 
in 2011, there were 8.7 million cases of TB, with 
nearly 1 million deaths among HIV-negative 
cases and 0.43 million deaths associated with 
HIV infection [1]. Case detection of all forms 
stood at 51%. The mortality rate for all forms of 
TB remains 27 per 100,000 populations (46,000 
deaths per year) [1]. Based on 2012 survey 
Nigeria ranked 4th among the highest 
tuberculosis burden countries in the world and 
first in Africa. The point estimates of TB 
prevalence rates were 318 and 524 per 100,000 
population (15 years and above) respectively [2]. 
 
Multidrug-resistant TB (MDR-TB) is TB that is 
resistant to atleast, rifampicin (RIF) and isoniazid 
(INH) the two most important first-line drugs with 
or without other first line drugs. In Nigeria, the 
national MDR-TB survey showed a prevalence of 
2.9% among new cases and 14.3% for 
retreatment cases [1]. Currently there are 2 
national Tuberculosis reference laboratories and 
6 zonal Tuberculosis reference laboratories for 
culture which generally use Lowenstein-Jensen 
(LJ) medium with limited use of liquid cultures. 
 
Indirect susceptibility testing on LJ medium is the 
most common method for detection of TB drug 
resistance in Africa. There is an urgent demand 
for early and proper detection of MDR and XDR-
TB cases for the effective management and 
control of TB. In recent years, a multitude of 
techniques for rapid DST has been designed and 
evaluated .However, the investment and 
recurrent costs is an obstacle for the broad 
implementation of these techniques in resource-
limited settings (RLSs) of Africa [3]. 
 
Global efforts for TB control, especially in 
resource limited settings, are being challenged 
by the lack of rapid, reliable and inexpensive 
techniques for the detection of M. tuberculosis. 
Results from the conventional culture detection 
methods come too late to influence a timely 
decision on patient management. Early detection 
is the key in both patient management and 
controlling transmission of M. tuberculosis. Liquid 
media systems such as the Mycobacterial 
Growth Indicator Tube (MGIT), are more rapid 
and detect more mycobacterial isolates than LJ 
[4]. The use of liquid systems the MGIT 960, has 
improved TAT to about 25–45 days. Liquid 
culture systems require expensive equipment 
and high biosafety level structures with constant 
electricity [5]. The traditional method for detection 
of MDR TB with indirect susceptibility testing, 
involving isolation of the bacterium followed by 
drug susceptibility testing (DST), has a long 
turnaround time (TAT) of 10 to 12 weeks [6]. 
Molecular tools such as Line Probe Assay (LPA) 
have been in use in Nigeria, but are expensive to 
run and require constant electricity. Therefore, 
faster, inexpensive and reliable tests are urgently 
needed [7].  
 
Nitrate Reductase Assay (NRA) is a simple 
colorimetric method that requires basic TB 
culture equipment with short turnaround 
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time.NRA is simple, inexpensive, reliable and 
reproducible test. Therefore, rapid, affordable, 
accurate and easy to use test for MDR-TB in 
Nigeria remains a priority. The aim of this study 
was to evaluate nitrate Reductase assay for 
detection of multi-drug resistant Tuberculosis 
compared to LJ proportion method, in Nigeria. 
 
2. MATERIALS AND METHODS  
 
2.1 Settings  
 
The NTBLTC is the largest TB referral center in 
northern Nigeria; NTBLTC serves as the National 
Training Center for community health workers 
and laboratory health personnel’s involved with 
Diagnosis of tuberculosis and treatment at the 
Peripheral, State and Zonal levels. This center is 
one of the two National TB reference laboratories 
that is equipped with TB biosafety level 3 (BSL-3) 
and TB molecular diagnostic laboratories. 
 
2.2 Sample Collection  
 
 A total of 437 re-treatment patients samples 
were collected and screened for Acid Fast Bacilli 
(AFB).Positive smears were culture on 
Lowenstein Jensen Media while culture positive 
samples were first identified for MTBC using 
immunochromatographic test kits.  
 
2.3 Preparation of Lowenstein- Jensen 
Medium with Drugs 
 
Isoniazid (INH), Streptomycin (STR), Rifampicin 
(RIF) and Ethambutol (EMB) were obtained as 
powder from Sigma Aldrich (Bornem, Belgium). 
Each drug was prepared at a concentration of 10 
mg/ml in sterile distilled water with the exception 
of RIF, which was dissolved in 
dimethylsulphuroxide (DMSO). Stock solutions 
were filtered (0.45 µm) sterilized and stored at -
70°C and used within six months. Different 
concentration of 0.2 µg/ml INH, 2 µg/ml EMB, 40 
µg/ml RIF and 4 µg/ml STR, were incorporated 
into LJ medium and then inspissated at 85°C for 
45 minutes. After preparation, the media were 
incubated for 48 hours at room temperature for 
sterility check before use [8]. 
 
2.4 Preparation of Lowenstein- Jensen 
Medium with KNO3 and Drugs 
 
Two grams of potassium nitrate were dissolved 
in 10 mls of sterile distilled water. And 1ml of 
prepared KNO3 was added to 200 ml of the drug 
containing and drug free LJ medium, dissolved 
by stirring, aliquoted and then inspissated for 45 
minutes at 85°C. After inspissations, the media 
was incubated for 48 hours at 37°C for sterility 
check before use. For NRA, the tubes containing 
LJ with antibiotics and KNO3 were used for the 
test while LJ with KNO3 were used as a control 
[8]. 
 
2.5 Drug Susceptibility Testing by 
Proportion Method 
 
The Indirect PM (IPM) was performed on LJ 
medium with the same recommended critical 
concentrations of antibiotics as mentioned 
previously. The culture of M. tuberculosis strain 
was harvested and suspended in tube containing 
sterile distilled water with 5-7 sterile glass beads 
then vortexed for about 30 seconds to 
homogenise the bacterial suspension and then 
allowed to stand for 15-30minutes for large 
aggrevates of bacteria to settle and turbidity of 
bacterial suspension was adjusted to match the 
McFarland turbidity No. 1. The original bacterial 
suspension was further diluted to 10-1, 10-2, 10-3 
and 10-4. The tubes were arranged in order of C1, 
C2, C3, S, I, R and E representing 10-2, 10-3 10-4, 
streptomycin, Isoniazid, Rifampicin and 
Ethambutol respectively. 
 
One in hundred dilutions (10-2) was inoculated 
into control (C1) and four (4) drugs (S I R E), 10-3 
dilution was inoculated into C2 and 10-4 was 
inoculated into C3 and then all tubes were 
incubated at 37°C for six weeks. Growth was 
recorded at 28 days and at 42 days as follows: 
3+ for confluent growth, 2+ for more than 100 
colonies, and 1-100 actual numbers of colonies. 
Susceptibility or resistance was recorded when 
the proportion of bacteria in drug-containing 
medium to that of drug free medium is < 1 or ≥ 1 
respectively. M. tuberculosis reference strains 
H37Rv (ATCC 27294) sensitive to first-line anti-
tuberculosis drugs, RIF-resistant (ATCC 35838), 
INH-resistant (ATCC 35822), EMB-resistant 
(ATCC 35837) and STR-resistant (ATCC 35820) 
were used as susceptible and resistant controls. 
All strains were sub cultured in Lowenstein–
Jensen (LJ) medium for 4 weeks before being 
studied [8].  
 
2.6 Drug Susceptibility Testing by Nitrate 
Reductase Assay  
 
Bacterial suspensions was made from a culture 
of MTB Isolates by dispensing a loopful of 
bacteria in 0.5 mL of sterile distilled water in 
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15mL falcon tube containing a few 3-mm 
diameter glass beads and vortexed to obtain a 
uniform solution., approximately 2.5 mL of sterile 
distilled water was added. The inoculum turbidity 
was adjusted to a McFarland tube no. 1 and 
diluted 1: 10 in sterile distilled water. Undiluted 
suspension (200 µ l) was inoculated into tubes of 
LJ medium with KNO3 (1 mg/ml) containing each 
of the drugs at the concentrations described 
above and 200 µ l of the 1 : 10 dilution was 
inoculated into three control tubes without 
antibiotics. The assay was developed with 
reagent mix (50% conc. HCl, 0.2% sulfanilamide 
and 0.1% N-(1-naphthyl) ethylene diamine 
dihydrochloride at ratio of 1: 2: 2) after 7 days of 
incubation at 37°C , a 0.5 ml of reagent mix was 
added to one control tube. When the clear 
reagent mixture turned pink, the drug-containing 
tubes were subsequently developed. When there 
was no colour change, the tubes were re-
incubated and the procedure repeated on days 
10 and 14. An isolate was considered resistant if 
the drug-containing tube produced a colour 
change that was more intense than the drug-free 
tube. M. tuberculosis reference strains H37Rv 
(ATCC 27294) sensitive to first-line anti-
tuberculosis drugs, RIF-resistant (ATCC 35838), 
INH-resistant (ATCC 35822), EMB-resistant 
(ATCC 35837) and STR-resistant (ATCC 35820) 
were used as susceptible and resistant controls. 
All strains were sub cultured in Lowenstein–
Jensen (LJ) medium for 4 weeks before being 
studied [9]. 
 
3. RESULTS AND DISCUSSION 
 
Drug susceptibility testing was performed on 
NRA to first line drugs on which fifty seven (57) 
confirmed isolates, showed highest resistance as 
against rifampicin (82.5%) followed by isoniazid 
resistance (77.2%). Streptomycin and 
ethambutol resistances were 65% and 51% 
respectively. Whereas ethambutol had highest 
number of susceptible isolates of 49%, 
streptomycin 35%, isoniazid 22.8% and 
rifampicin (17.5%) with lowest susceptible was 
recorded as shown in Table 1.  
 
Multi-drug resistant tuberculosis is most difficult 
and expensive for management and treatment 
during the recent years is an increasing. Rapid 
detection of MDR strains is therefore needed to 
stop their spread in the population. Current 
methods for DST of MTB are either costly or very 
slow. So, a cost-effective and rapid drug-
susceptibility method is required to guide the 
treatment of TB. NRA result of Bwanga et al. [10] 
in Uganda NRA was suggest that NRA is the 
most sensitive, specific, and cheapest test for 
MDR-TB in low income settings. Rapid detection 
of MDR-TB and thereby rapid drug susceptibility 
testing (DST) to first line drugs, are critically 
important to the successful control of TB [11]. 
 
The results of drug susceptibility testing by NRA 
indicate that the resistance rate was higher as 
against of isoniazid and rifampicin, which are the 
most important first line drugs used for the 
treatment of tuberculosis. This could be as a 
result of overuse of these drugs for the treatment 
of TB. This is in agreement with the work of 
Mahadev et al. [12] and Iqbal et al. [13] who 
reported higher resistance to rifampicin and 
isoniazid. 
 
The sensitivity and specificity of NRA compared 
to that of LJPM were observed to be 98% and 
89%, 98% and 92%, 64% and 80%, 68% and 
77% for RIF, INH, STR, and EMB respectively. 
Positive predictive values were 91%, 93%, 87% 
and 83% for RIF, INH, STR and EMB 
respectively. Negative predictive values were 
80%, 92%, 67% and 90% for RIF, INH, STR and 
EMB respectively. Overall, the sensitivity, 
specificity, positive predictive value and negative 
predictive value of NRA in detecting MDR-TB 
were 90%, 82%, 85%and 73% respectively. 
Good agreement was found in all the tests with κ 
values of 0.63, 0.61, 0.61 and 0.62 for RIF, INH, 
EMB and MDR-TB respectively only STR shows 
moderate agreements with k value of 0.59        
(Table 2).  
 
When the results of NRA and LJ PM were 
compared, higher agreement was observed for 
RIF and INH, however there were disagreements 
in relation to the antibiotics EMB and STR. The 
factors which led to lower specificity and 
sensitivity values of LJ could be as a result of 
degradation of the antibiotics in LJ medium. The 
higher rate of detection of RIF resistance by NRA 
method is the reason for the use of NRA for the 
screening of MDR strains, as resistance to RIF is 
a marker for MDR detection. Most studies have 
shown high sensitivity and specificity values for 
INH and RIF, the two most important drugs used 
for TB treatment [9,14,15]. 
 
In a multicentre study, the NRA was evaluated in 
different settings to determine the susceptibility 
of M. tuberculosis to first-line anti-tuberculosis 
drugs. Higher accuracy of 96.6% was observed 
for INH and RIF, while that for STR and EMB 
were lower (85.3%) [16]. Percentage agreement 
of 98.3%, 98.3%, 90.8% and 93.3% by NRA 
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Table 1. Drug susceptibility of Mycobacterium tuberculosis complex by nitrate reductase 
assay 
 
Drugs  Streptomycin  Isoniazid  Rifampicin Ethambutol 
Resistance 
Susceptible 
 37(65%) 
20(35%) 
44(77.2%) 
13(22.8%) 
47(82.5%) 
10(17.5%) 
29(59%) 
28(49%) 
Key=MDR-TB = multidrug resistant tuberculosis, NRA = nitrate reductase assay, LJPM = Lowenstein Jensen 
proportion Method 
 
Table 2. Evaluation of drug susceptibility testing of Mycobacterium tuberculosis using nitrate 
reductase assay and LJ proportion method 
 
Drugs  Sensitivity (%)  Specificity (%) PPV (%)  NPV (%) κ-statistic 
Streptomycin  
Isoniazid 
Rifampicin 
Ethambutol 
MDR-TB 
 64 
98 
98 
68 
90 
80 
92 
89 
77 
82 
87 
93 
91 
83 
85 
67 
92 
80 
90 
73 
0.59 
0.61 
0.63 
0.61 
0.62 
Key: PPV = positive predictive value, NPV = negative predictive value, κ = kappa 
 
were observed for INH, RIF, STR and EMB 
respectively by Shikama et al. [17]. However, 
similar lower sensitivity and specificity for STR 
and EMB have also been reported by Lemus et 
al. [18] and Montoro et al. [19] as also reported in 
this study. 
 
Lemus et al. [18] in India also observed 
sensitivity of 91.7%, 96.5%, 88.0% and 93.9% for 
INH, STR, EMB and RIF, respectively, and then 
specificity was higher than 99.1% for all of the 
drugs. While in this study higher sensitivity for 
INH and RIF was observed to be 98% and this 
could be as the result of the patients categories 
used for the study. Visalakshi et al. [20] observed 
sensitivity and specificity of the direct NRA and 
indirect LJPM to be 94% and 98%, and 100% 
and 98% for RIF and INH respectively which is 
similar to the result obtained in the study. 
Moreover, Bwanga et al. [10] in Uganda stated 
98% sensitivity and specificity of NRA for RIF 
and 98% sensitivity and 94% specificity of NRA 
for INH. In another study of Gupta et al., [21] 
sensitivity of NRA was 98.4% ,97% 88.5% and 
94.5% for RIF, INH, STR and EMB with 99 % 
agreement between the results of NRA and 
LJPM for INH and RIF while this study have 
reported lower sensitivity for STR and EMB. 
 
The higher detection rate of MDR-TB by NRA 
could be as a result of borderline that exhibit 
color change lower than that obtained in the 
control tube and therefore this borderline isolate 
are frequently associated with problems of 
interpretation of DST by NRA. Bacterial 
contamination may cause false positive results 
and low inoculation in the media could also result 
in false positive result [22]. More than half of 
MDR-TB isolates were resistant to all four first-
line anti tuberculosis drugs tested. Re-treatment 
cases were significantly more likely to have 
MDR-TB than non-MDR-TB. Previous studies 
have shown that resistance to rifampicin is a 
significant predictor of resistance to isoniazid and 
streptomycin; isolates resistant to rifampicin were 
also resistant to isoniazid and streptomycin [23].  
 
4. CONCLUSION 
 
In the context of emergence of MDR-TB, the 
NRA may be of great importance due to its 
higher sensitivity and specificity for the rapid 
detection of rifampicin and isoniazid resistance, 
the two most important drugs for tuberculosis 
treatment. On the basis of the findings, NRA has 
the potential to be a useful tool for accurate 
detection of MDR-TB in the study area. 
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